Global Nucleic Acid Isolation & Purification Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Nucleic Acid Isolation & Purification Market size is expected to reach USD 12.99 Billion in 2034 from USD 6.38 Billion (2025) growing at a CAGR of 8.21% during 2026-2034.

The global nucleic acid isolation and purification market has expanded significantly due to rising molecular diagnostics, genomics research, and personalized medicine initiatives. These technologies are essential for extracting DNA and RNA from biological samples for downstream applications such as PCR, sequencing, and cloning. The COVID-19 pandemic accelerated demand for reliable extraction kits, automation systems, and magnetic bead-based purification methods, strengthening laboratory infrastructure worldwide.

Key drivers include growing adoption of next-generation sequencing (NGS), increasing prevalence of infectious and genetic diseases, and expansion of biotech and pharmaceutical R&D. Automation and high-throughput platforms have improved efficiency and reproducibility in clinical and research laboratories. Government funding for genomics projects and advancements in sample preparation technologies further stimulate market growth across academic, diagnostic, and industrial sectors.

Future prospects are promising, with sustained demand from precision medicine, liquid biopsy, and gene therapy development. Miniaturized, rapid, and automated extraction solutions will gain traction, especially in point-of-care diagnostics. Emerging economies investing in molecular testing capacity will create additional opportunities. However, cost sensitivity and the need for standardized protocols may influence competitive dynamics.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

Reagents & Kits
Instruments

By Type

Rna Isolation & Purification
Mrna Isolation & Purification
Mirna Isolation & Purification
Total Rna Isolation & Purification
Other Rna Isolation & Purification Types
Dna Isolation & Purification
Genomic Dna Isolation & Purification
Plasmid Dna Isolation & Purification
Viral Dna Isolation & Purification
Other Dna Isolation & Purification Types

By Method

Magnetic Beads
Column-Based
Reagent-Based
Other Methods

By Application

Diagnostics
Drug Discovery & Development
Precision Medicine
Other Applications

By End-Use

Hospitals And Diagnostic Centers
Pharmaceutical & Biotechnology Companies
Contract Research Organizations
Other End-Users

COMPANIES PROFILED

Qiagen NV, Thermo Fisher Scientific Inc, Illumina Inc, Danaher Corporation, F Hoffmann La Roche Ltd, Merck KGaA, Agilent Technologies Inc, BioRad Laboratories, Takara Bio Inc, Promega Corporation, New England Biolabs, Abcam plc, PCR Biosystems
We can customise the report as per your requirements.

Product Code: VMR11218749

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY PRODUCT 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Product
4.2. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY TYPE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Type
5.2. Rna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Mrna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.4. Mirna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.5. Total Rna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.6. Other Rna Isolation & Purification Types Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.7. Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.8. Genomic Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.9. Plasmid Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.10. Viral Dna Isolation & Purification Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.11. Other Dna Isolation & Purification Types Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY METHOD 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Method
6.2. Magnetic Beads Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. Column-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Reagent-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Other Methods Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY APPLICATION 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast Application
7.2. Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Drug Discovery & Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Precision Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.5. Other Applications Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY END-USE 2022-2034 (USD MN)

8.1. Market Analysis, Insights and Forecast End-use
8.2. Hospitals And Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
8.5. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION MARKET: BY REGION 2022-2034(USD MN)

9.1. Regional Outlook
9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.2.1 By Product
- 9.2.2 By Type
- 9.2.3 By Method
- 9.2.4 By Application
- 9.2.5 By End-use
- 9.2.6 United States
- 9.2.7 Canada
- 9.2.8 Mexico
9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.3.1 By Product
- 9.3.2 By Type
- 9.3.3 By Method
- 9.3.4 By Application
- 9.3.5 By End-use
- 9.3.6 United Kingdom
- 9.3.7 France
- 9.3.8 Germany
- 9.3.9 Italy
- 9.3.10 Russia
- 9.3.11 Rest Of Europe
9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.4.1 By Product
- 9.4.2 By Type
- 9.4.3 By Method
- 9.4.4 By Application
- 9.4.5 By End-use
- 9.4.6 India
- 9.4.7 Japan
- 9.4.8 South Korea
- 9.4.9 Australia
- 9.4.10 South East Asia
- 9.4.11 Rest Of Asia Pacific
9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.5.1 By Product
- 9.5.2 By Type
- 9.5.3 By Method
- 9.5.4 By Application
- 9.5.5 By End-use
- 9.5.6 Brazil
- 9.5.7 Argentina
- 9.5.8 Peru
- 9.5.9 Chile
- 9.5.10 South East Asia
- 9.5.11 Rest of Latin America
9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 9.6.1 By Product
- 9.6.2 By Type
- 9.6.3 By Method
- 9.6.4 By Application
- 9.6.5 By End-use
- 9.6.6 Saudi Arabia
- 9.6.7 UAE
- 9.6.8 Israel
- 9.6.9 South Africa
- 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

10.1. Recent Developments
10.2. Company Categorization
10.3. Supply Chain & Channel Partners (based on availability)
10.4. Market Share & Positioning Analysis (based on availability)
10.5. Vendor Landscape (based on availability)
10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL NUCLEIC ACID ISOLATION & PURIFICATION INDUSTRY

11.1. Top Companies Market Share Analysis
11.2. Company Profiles
- 11.2.1 Qiagen N.V
- 11.2.2 Thermo Fisher Scientific Inc
- 11.2.3 Illumina Inc
- 11.2.4 Danaher Corporation
- 11.2.5 F. Hoffmann La Roche Ltd
- 11.2.6 Merck KGaA
- 11.2.7 Agilent Technologies Inc
- 11.2.8 Bio-Rad Laboratories
- 11.2.9 Takara Bio Inc
- 11.2.10 Promega Corporation
- 11.2.11 New England Biolabs
- 11.2.12 Abcam Plc
- 11.2.13 PCR Biosystems